News
4317 posts · page 12 of 180
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics, newly listed on the stock exchange, posts a Rs 52.7 crore profit in Q1, rebounding from a loss last year.
Indian AI Platform iOncology.ai Gains Spotlight at BRICS Summit
iOncology.ai, a breakthrough Indian AI platform for cancer care, is highlighted in the BRICS Health Journal, showcasing its potential to transform cancer treatment.
Waystar Considers Sale Amid Market Challenges, Sources Reveal
Waystar, a healthcare software firm, is exploring strategic options including a sale, as its market value drops to $4.8 billion.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a potential $1 billion acquisition of Sofie Biosciences, a leader in cancer diagnostic chemicals.
Molbio Diagnostics Reports Rs 52.7 Cr Profit in Q1 Post-IPO
Molbio Diagnostics posts Rs 52.74 crore profit in Q1, rebounding from last year's loss.
Indian AI Cancer Platform iOncology.ai Gains Global Spotlight at BRICS Summit
iOncology.ai, an Indian AI platform for cancer care, is featured in BRICS Health Journal, highlighting its potential to transform cancer treatment in emerging economies.
Waystar Mulls Sale Amid Falling Market Value, Sources Reveal
Healthcare software firm Waystar considers potential sale after a sharp stock decline.
Trump Advocates for Medicaid Drug Cost Alignment with Global Standards
Trump announces all states' participation in a program to align Medicaid drug prices with international rates.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in radiopharmaceuticals for cancer diagnostics.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics turns a profit of Rs 52.7 crore in Q1, following its Rs 940 crore IPO and significant growth in Truenat test-kit sales.
Indian AI Cancer Platform Gains Global Attention at BRICS Summit
iOncology.ai, an AI platform for cancer care, is spotlighted in the BRICS Health Journal, aiming to transform cancer treatment in emerging economies.
Waystar Considers Sale Amid Stock Decline, Sources Reveal
Healthcare software firm Waystar is exploring a potential sale, guided by Evercore, as its market value drops to $4.8 billion.
Trump Pushes A.I. in Healthcare Amid Safety Concerns
The Trump administration's push to embed A.I. in healthcare sparks debate over safety and investor influence.
Gov. Shapiro Urges Trump to Replace HHS Secretary Amid Measles Crisis
Governor Josh Shapiro calls for the removal of HHS Secretary RFK Jr. as measles cases escalate.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is reportedly in talks to acquire Sofie Biosciences for $1 billion, bolstering its pharmaceutical diagnostics division.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics turns profitable, posting Rs 52.7 crore in Q1 after raising Rs 940 crore via IPO.
Indian AI Platform iOncology.ai Gains Global Spotlight at BRICS Summit
iOncology.ai, India's AI-based cancer care platform, is featured in a BRICS health journal, showcasing its potential to transform cancer treatment in emerging economies.
Waystar Considers Sale Amid Market Challenges, Sources Reveal
Waystar explores strategic options, including a potential sale, as its market value dips amid software sector challenges.
Trump Administration Advances A.I. in Healthcare Amid Safety Concerns
New federal initiatives are deploying A.I. in therapy and prescriptions, sparking safety and investor influence worries.
First mRNA Flu Vaccine mFlusiva Now Available for Older Adults
Moderna's mRNA flu shot, mFlusiva, is now available for those 50 and older, offering a faster production timeline.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion deal to acquire Sofie Biosciences, a leader in cancer scan chemicals.
Molbio Diagnostics Reports Rs 52.7 Crore Q1 Profit Following IPO
Molbio Diagnostics posts Rs 52.7 crore profit in Q1, reversing last year's loss, driven by Truenat test-kit sales.
Indian AI Platform for Cancer Care Spotlighted at BRICS Summit
iOncology.ai, an AI platform for cancer care from India, features in BRICS Health Journal, highlighting its potential to transform cancer treatment in emerging economies.
Waystar Considers Sale Amid Software Sector Challenges
Waystar, a healthcare software firm, is exploring a sale as its market value drops amid sector challenges.